The Insulin-Like Growth Factor (IGF) is a peptide hormone which is similar to insulin in structure and function. It is primarily produced in the liver and acts as a growth factor in the body. IGF plays a critical role in many aspects of human growth and development, including its effects on muscle, bone, and tissue growth. IGF works by binding to its receptor on the cell surface and stimulating the production of insulin-like growth factors (IGFs). These IGFs are responsible for the growth and development of cells, tissues, and organs.
IGF levels are highest in infants and children and decrease with age. IGF is also thought to play a role in the regulation of metabolism, cell division, and apoptosis (programmed cell death). It has been suggested that IGF is involved in the regulation of aging and various metabolic processes, such as glucose metabolism and lipid metabolism.
IGF is important in the regulation of growth hormone (GH) and is believed to be involved in the regulation of metabolism. IGF has also been found to have anti-inflammatory properties and is thought to be involved in the regulation of immune responses and wound healing.
In addition to its normal physiological roles, IGF has been found to play a role in several diseases, including cancer, obesity, diabetes, and neurodegenerative diseases. IGF has been identified as a potential therapeutic target for a variety of diseases, including cancer, diabetes, and obesity.